Essential Continuous Glucose Monitoring Metrics: The Principal Dimensions of Glycemic Control in Diabetes

A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

(2022) David C. Klonoff et al.   Journal of diabetes science and technology

One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop Technology

(2021) Marc D. Breton et al.   Diabetes Technology & Therapeutics

Quality of Glycemic Control: Assessment Using Relationships Between Metrics for Safety and Efficacy

(2021) David Rodbard   Diabetes Technology & Therapeutics

Impact of a Novel Diabetes Support System on a Cohort of Individuals With Type 1 Diabetes Treated With Multiple Daily Injections: A Multicenter Randomized Study

(2021) Alessandro Bisio et al.   DIABETES CARE

Randomized Controlled Trial of Mobile Closed-Loop Control

(2020) Boris Kovatchev et al.   DIABETES CARE

A Review of Continuous Glucose Monitoring-Based Composite Metrics for Glycemic Control

(2020) Michelle Nguyen et al.   Diabetes Technology & Therapeutics

A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes

(2020) Marc D. Breton et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

(2019) Tadej Battelino et al.   DIABETES CARE

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes

(2019) Sue A. Brown et al.   NEW ENGLAND JOURNAL OF MEDICINE

How Should We Assess Glycemic Variability in Type 1 Diabetes? Contribution of Principal Component Analysis for Interstitial Glucose Indices in 142 Children

(2018) Sophie Guilmin-Crépon et al.   Diabetes Technology & Therapeutics

Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring

(2018) Richard M. Bergenstal et al.   DIABETES CARE

Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections

(2017) Marcus Lind et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections

(2017) Roy W. Beck et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Metrics for glycaemic control — from HbA1c to continuous glucose monitoring

(2017) Boris P. Kovatchev   Nature Reviews Endocrinology

Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial

(2017) Roy W Beck et al.   Lancet Diabetes & Endocrinology

Glucose Variability: Timing, Risk Analysis, and Relationship to Hypoglycemia in Diabetes

(2016) Boris Kovatchev et al.   DIABETES CARE

Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes

(2016) Richard M. Bergenstal et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Glycemic Goals in Diabetes: Trade-off Between Glycemic Control and Iatrogenic Hypoglycemia

(2014) P. E. Cryer   DIABETES

Closed-Loop Artificial Pancreas Systems: Engineering the Algorithms

(2014) Francis J. Doyle et al.   DIABETES CARE

Glucose Variability Indices in Type 1 Diabetes: Parsimonious Set of Indices Revealed by Sparse Principal Component Analysis

(2014) Chiara Fabris et al.   Diabetes Technology & Therapeutics

Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile (AGP)

(2013) Richard M. Bergenstal et al.   Diabetes Technology & Therapeutics

Optimal Sampling Intervals to Assess Long-Term Glycemic Control Using Continuous Glucose Monitoring

(2011) Dongyuan Xing et al.   Diabetes Technology & Therapeutics

Statistical Tools to Analyze Continuous Glucose Monitor Data

(2009) William Clarke et al.   Diabetes Technology & Therapeutics

Interpretation of Continuous Glucose Monitoring Data: Glycemic Variability and Quality of Glycemic Control

(2009) David Rodbard   Diabetes Technology & Therapeutics